Bicocca Open Archive

Logo unimib boa
MASSERINI, MASSIMO ERNESTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.726
EU - Europa 8.000
AS - Asia 6.824
SA - Sud America 1.020
AF - Africa 136
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 25
Totale 31.760
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.257
CN - Cina 2.260
SG - Singapore 2.213
DE - Germania 1.375
IT - Italia 1.242
SE - Svezia 1.181
HK - Hong Kong 1.016
RU - Federazione Russa 996
IE - Irlanda 870
BR - Brasile 817
UA - Ucraina 704
GB - Regno Unito 512
CA - Canada 397
VN - Vietnam 388
IN - India 268
FI - Finlandia 248
FR - Francia 172
PL - Polonia 167
KR - Corea 129
AT - Austria 113
DK - Danimarca 84
AR - Argentina 83
TR - Turchia 73
JP - Giappone 71
ZA - Sudafrica 71
NL - Olanda 70
BE - Belgio 68
IR - Iran 67
BD - Bangladesh 60
MX - Messico 52
ID - Indonesia 50
ES - Italia 48
BG - Bulgaria 38
IQ - Iraq 38
PK - Pakistan 26
PT - Portogallo 26
AU - Australia 24
EC - Ecuador 24
VE - Venezuela 24
EU - Europa 23
CL - Cile 18
TW - Taiwan 18
CH - Svizzera 16
CO - Colombia 16
CZ - Repubblica Ceca 16
UZ - Uzbekistan 16
IL - Israele 14
PY - Paraguay 14
RO - Romania 14
EG - Egitto 13
SA - Arabia Saudita 13
MA - Marocco 12
MY - Malesia 12
NP - Nepal 12
LT - Lituania 11
JO - Giordania 10
KE - Kenya 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
LB - Libano 8
HU - Ungheria 7
PE - Perù 7
AZ - Azerbaigian 6
DZ - Algeria 6
GR - Grecia 6
KZ - Kazakistan 6
OM - Oman 6
TH - Thailandia 6
BO - Bolivia 5
JM - Giamaica 5
ET - Etiopia 4
NZ - Nuova Zelanda 4
PH - Filippine 4
SN - Senegal 4
TN - Tunisia 4
AO - Angola 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
LK - Sri Lanka 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
MU - Mauritius 3
NO - Norvegia 3
YE - Yemen 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GE - Georgia 2
KH - Cambogia 2
LU - Lussemburgo 2
LV - Lettonia 2
LY - Libia 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
CY - Cipro 1
Totale 31.743
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.238
Woodbridge 1.577
Singapore 1.326
Ashburn 1.244
Chandler 1.058
Hong Kong 990
Houston 881
Dublin 847
Fairfield 832
Jacksonville 753
Frankfurt am Main 734
Wilmington 613
Dearborn 597
Milan 551
Beijing 409
Seattle 397
New York 369
Santa Clara 349
Cambridge 297
Princeton 278
Dallas 231
Nanjing 223
Los Angeles 222
Hefei 197
Shanghai 169
Lachine 127
Kraków 114
Lawrence 110
Toronto 110
Seoul 105
Altamura 103
The Dalles 101
Ho Chi Minh City 98
Guangzhou 97
Helsinki 95
Vienna 95
Buffalo 88
Chicago 87
Moscow 85
Nanchang 82
São Paulo 80
Council Bluffs 78
Hangzhou 77
Hanoi 71
Boardman 68
Ottawa 66
San Diego 66
Brussels 62
Changsha 57
Dong Ket 55
Andover 51
Tokyo 51
Fremont 49
Tianjin 48
Shenyang 46
Wayne 43
Falls Church 38
London 38
Plovdiv 37
Hebei 36
Jiaxing 36
Jinan 36
Rome 35
Brooklyn 34
Munich 34
Warsaw 34
Zhengzhou 33
Mountain View 31
Nürnberg 31
Jakarta 30
Chennai 28
Johannesburg 28
Montreal 28
Auburn Hills 27
Kunming 27
Stockholm 27
Columbus 26
Salt Lake City 25
Atlanta 24
Denver 24
Norwalk 24
Manchester 22
Mumbai 22
Grafing 21
Ningbo 21
Rio de Janeiro 21
Huizen 20
Redmond 20
Ankara 19
Boston 19
Nuremberg 19
Orem 19
Pune 19
Tampa 19
New Delhi 18
Poplar 17
Amsterdam 16
Belo Horizonte 16
Montréal 16
Phoenix 16
Totale 20.978
Salva come PNG Salva come JPEG
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 638
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 462
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 423
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 419
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 407
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 397
Nanomedicine for the treatment of Alzheimer's disease 382
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 371
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 371
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 361
Morphogenic effect of common solvent in the self-assembly behavior of amphiphilic PEO-b-PLA 357
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 346
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 345
Enhanced brain targeting of engineered solid lipid nanoparticles 336
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 334
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 329
Versatile and efficient targeting using a single nanoparticulate platform: Application to cancer and alzheimer's disease 327
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 321
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 313
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 306
TrkA pathway activation induced by amyloid-beta (Abeta) 302
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 299
Curcumin derivatives as new ligands of Aβ peptides 299
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 296
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 295
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 287
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 287
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 286
Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds 285
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 277
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 277
Developmental changes in the protein composition of sphingolipid- and cholesterol-enriched membrane domains of rat cerebellar granule cells 273
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 272
Effect of modified collagen on amyloid beta peptide aggregation 271
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 269
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 264
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 260
Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor 256
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 255
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 253
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 253
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 252
Detection and Characterization of Different Brain-Derived Subpopulations of Plasma Exosomes by Surface Plasmon Resonance Imaging 246
Palmitic is the main fatty acid carried by lipids of detergent-resistant membrane fractions from neural and non-neural cells 245
Role of lipid rafts and GM1 in the segregation and processing of Prion Protein 244
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 241
Enhanced brain targeting of engineered solid lipid nanoparticles 237
Inhibition of murine leukemia (WEHI-3B and L1210) proliferation by cholera toxin B subunit 234
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 233
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 233
mApoE-Functionalized Nanoliposomes Delivering Doxorubicin and Ultrasmall Superparamagnetic Iron Oxide to Glioblastoma Cells Characterized by TEM and Confocal Microscopy 232
Immunoseparation of Prion protein-enriched domains from other detergent-resistant membrane fractions, isolated from neuronal cells 231
Pin1 affects Tau phosphorylation in response to Abeta oligomers 231
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 229
Pin1: A new outlook in alzheimer's disease 229
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 229
Ceramides and sphingomyelinases in senile plaques 229
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 227
Interactions of proteins with ganglioside-enriched microdomains on the membrane: the lateral phase separation of molecular species of GD1a ganglioside, having homogeneous long-chain base composition, is recognized by Vibrio cholerae sialidase 225
Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin 223
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 223
Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients 222
A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease 222
Age-related changes in the ceramide composition of the major gangliosides present in rat brain subcellular fractions enriched in plasma membranes of neuronal and myelin origin 220
Role of phosphatidylethanol in membranes. Effects on membrane fluidity, tolerance to ethanol, and activity of membrane-bound enzymes 219
Dependence of rat liver CMP-N-acetylneuraminate:GM1 sialyltransferase (SAT IV) activity on the ceramide composition of GM1 ganglioside 219
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 219
Nanomedicine for the treatment of Alzheimer's disease 219
Ischemic conditions and β-secretase activation: The impact of membrane cholesterol enrichment as triggering factor in rat brain endothelial cells 219
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 216
Two tail-anchored protein variants, differing in transmembrane domain length and intracellular sorting, interact differently with lipids 214
Abnormal cross-talk between mutant presenilin 1 (I143T, G384A) and glycosphingolipid biosynthesis 214
A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface 213
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 210
ALCOHOL AND NEURAL LIPIDS 209
Raman spectroscopy uncovers biochemical tissue-related features of extracellular vesicles from mesenchymal stromal cells 209
Functionalization with curcumin-derivative and TAT peptide enhances the interaction with human brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 207
Nanotechnology for neurodegenerative disorders 206
Methyl-β-cyclodextrin treatment affects the thermotropic behaviour of membranes and detergent-resistant membrane fractions of cultured A431 cells 205
Thermotropic behavior of fatty acid ethyl esters in phospholipid liposomes 204
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 204
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 204
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 204
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 202
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 202
Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi β amiloidi (Aβ) 200
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 200
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 198
Changes in the composition of detergent-resistant membrane domains of cultured neurons following protein kinase C activation 197
Association to HeLa cells and surface behavior of exogenous gangliosides studied with a fluorescent derivative of GM1 196
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 195
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 194
A surveillance system for early-stage diagnosis of endogenous diseases by swarms of nanobots 193
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 192
Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications 192
New tricyclic compounds, process for their manufacture and their use as ligands of beta-alyloid peptides 191
Early-Stage Diagnosis of Endogenous Diseases by Swarms of Nanobots: An Applicative Scenario 191
Influence of glycolipid oligosaccharide and long-chain base composition on the thermotropic properties of dipalmitoylphosphatidylcholine large unilamellar vesicles containing gangliosides 191
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 188
Nanotechnology for neurodegenerative disorders 186
Totale 26.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.853
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.378 0 0 0 0 0 165 269 153 236 258 96 201
2021/20221.838 98 167 176 189 76 175 142 100 104 169 158 284
2022/20233.854 449 1.198 338 396 230 562 37 220 260 25 86 53
2023/20242.561 66 84 137 146 328 678 554 121 158 33 37 219
2024/20254.641 244 541 267 214 430 210 259 213 418 716 380 749
2025/20266.086 1.268 639 1.094 1.285 1.496 304 0 0 0 0 0 0
Totale 32.448